Curevac N.V. (CVAC)
2.84 -0.01 (-0.35%) 10:38 ET [NASDAQ]
2.84 x 400 2.85 x 128
Realtime by (Cboe BZX)
2.84 x 400 2.85 x 128
Realtime 2.88 +0.03 (+1.05%) 09:28 ET
for Thu, Mar 27th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CVAC | AZN | AMGN | GILD | VRTX |
| Company | Curevac N.V. | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.85 | 72.43 | 306.22 | 110.00 | 498.59 |
| High | 2.90 | 72.73 | 307.57 | 111.81 | 506.54 |
| Low | 2.84 | 72.37 | 304.29 | 109.74 | 498.59 |
| Last | 2.84 | 72.63 | 306.31 | 110.81 | 504.03 |
| Change | -0.01 | -0.09 | +0.60 | +1.54 | +3.75 |
| % Change | -0.35% | -0.12% | +0.20% | +1.41% | +0.75% |
| Volume | 106,584 | 655,455 | 258,329 | 1,275,980 | 118,856 |
| 20-Day Average Volume | 511,400 | 5,565,728 | 3,038,652 | 10,692,458 | 1,343,031 |
| Previous Close | 2.85 | 72.72 | 305.71 | 109.27 | 500.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.02 | 75.85 | 314.62 | 112.10 | 499.15 |
| 20-Day Raw Stochastic | 5.68% | 11.63% | 12.00% | 40.37% | 64.68% |
| 20-Day Relative Strength | 40.04% | 44.53% | 51.49% | 56.96% | 58.33% |
| Weighted Alpha | -21.29 | +3.46 | +6.93 | +59.69 | +20.69 |
| Today's Opinion | 48% Sell | 8% Sell | 32% Buy | 80% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 24% Sell | 16% Buy | 80% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 24% Buy | 24% Buy | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.87% since 03/20/25 | -5.15% since 03/20/25 | -2.43% since 03/20/25 | +4.71% since 03/20/25 | -1.30% since 03/20/25 |
| Low | 2.83 on 03/21/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.92 on 03/21/25 | 497.78 on 03/26/25 |
| High | 3.10 on 03/25/25 | 75.90 on 03/21/25 | 317.58 on 03/24/25 | 111.81 on 03/27/25 | 513.97 on 03/24/25 |
| 1-Month | |||||
| %Chg | -6.70% since 02/27/25 | -4.06% since 02/27/25 | +0.52% since 02/27/25 | -1.01% since 02/27/25 | +6.12% since 02/27/25 |
| Low | 2.83 on 03/21/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 104.70 on 03/20/25 | 474.01 on 02/28/25 |
| High | 3.27 on 03/03/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 3-Month | |||||
| %Chg | -9.94% since 12/27/24 | +9.54% since 12/27/24 | +17.04% since 12/27/24 | +17.80% since 12/27/24 | +23.19% since 12/27/24 |
| Low | 2.83 on 03/21/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 397.24 on 01/13/25 |
| High | 5.00 on 01/07/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -4.83% since 09/27/24 | -6.49% since 09/27/24 | -4.73% since 09/27/24 | +32.59% since 09/27/24 | +8.79% since 09/27/24 |
| Low | 2.37 on 11/20/24 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 82.82 on 10/01/24 | 377.85 on 12/19/24 |
| High | 5.00 on 01/07/25 | 79.76 on 10/02/24 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 638,058 | 225,520,304 | 164,228,944 | 136,078,944 | 128,466,912 |
| Shares Outstanding, K | 223,880 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
| Annual Sales | 58,180,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -281,580,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 543,090,000 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | 371,710,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 2.53 | 0.41 | 0.53 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.65 on 11/12/24 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 04/23/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 5.29 | 17.77 | 15.48 | 23.40 | 0.00 |